We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Human Somatic Cells Identified by Their Locomotion Pattern

By Biotechdaily staff writers
Posted on 19 Jun 2008
A novel sensor will enable human somatic cells to be identified based on their characteristic locomotion pattern. More...
The sensor is expected to facilitate the diagnosis of diseases or assessment of healing processes.

The sensor consists of a smooth surface that is studded with 250,000 tiny plastic columns measuring five microns in diameter. These columns are made of elastic polyurethane plastic. When a cell glides across them, it very slightly bends them sideways. This deflection is registered by a digital camera and analyzed by a special software program.

Manufacturing the sensor, which is called Cellforce, was complicated. The columns had to be coated in such a way that living cells were happy to move across their tips. The cells would otherwise avoid the tips and continue their journey lower down between the columns. In that case, there would be no deflection at all. The microscope required for cell magnification had to be adapted to suit the application. In order to build the delicate column structure, liquid plastic was pressed into a negative mold at a pressure of 2000 bar and allowed to harden. To allow cost-effective production of the Cellforce sensor in the future, commercially available plastics and well-established techniques from chip manufacture will be utilized.

The Cellforce sensor was devised and manufactured by scientists at the Fraunhofer Institute for Applied Optics and Precision Engineering (Institute Angewandte Optik und Feinmechanik) IOF (Jena, Germany). The project manager, Dr. Norbert Danz commented, "Analysis of cell locomotion is important for numerous applications. It could be used to check whether bone cells are successfully populating an implant, or how well a wound is healing.”

The scientists have already shown that their Cellforce sensor works. The Cellforce prototype is expected to be ready in the year 2009. It will be the task of initial biological tests to show how different cell types behave.


Related Links:
Institute for Applied Optics and Precision Engineering IOF

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.